Gene Therapy Milestone and AI in Oncology
Kilder
- biospace.com: FDA approval of Regeneron’s hearing loss gene therapy breaks barriers - BioSpace
- bioworld.com: A free gene therapy? Regeneron’s Otarmeni approved for hearing loss - BioWorld News
- Statnews: CMS, FDA team up to fast-track reimbursement for breakthrough devices - statnews.com
- statnews.com: CMS, FDA team up to fast-track reimbursement for breakthrough devices - statnews.com
- raps.org: Recon: FDA approves Regeneron’s hearing loss gene therapy; Novo’s oral diabetes drug reduced blood sugar in children in Phase 3a study - RAPS.org
- bioworld.com: FDA, CMS partner to deliver RAPIDly for innovative devices - BioWorld News
- Genengnews: CRISPR Base Editing Repairs Hard-to-Treat Cystic Fibrosis Mutation in Cell Models - Genetic Engineering and Biotechnology News
- genengnews.com: CRISPR Base Editing Repairs Hard-to-Treat Cystic Fibrosis Mutation in Cell Models - Genetic Engineering and Biotechnology News
- genengnews.com: Heart’s Constant Beating Suppresses Tumor Growth in Cardiac Tissues - Genetic Engineering and Biotechnology News
- Bioworld: AACR 2026: The age of agentic AI in oncology - BioWorld News
- bioworld.com: AACR 2026: The age of agentic AI in oncology - BioWorld News
- Nature: cardiac macrophages suppresses atrial fibrillation - Nature
- nature.com: cardiac macrophages suppresses atrial fibrillation - Nature
- Fiercebiotech: Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D - Fierce Biotech
- fiercebiotech.com: Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D - Fierce Biotech
- wikimedia: Photo by Airman 1st Class Amber Carter / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.